Evidence map›Paper›PMID 16603628›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2006

Bispecific abs against modified protein and DNA with oxidized lipids.

Mitsugu Akagawa, Sohei Ito, Kazuyo Toyoda, Yoshihisa Ishii, Emi Tatsuda, Takahiro Shibata, Satoru Yamaguchi, Yoshichika Kawai, Kousuke Ishino, Yusuke Kishi and 6 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Detection of electrophile-sensitive proteins.Biochimica et biophysica acta · 2014
    Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Crystallization and molecular-replacement studies of the monoclonal antibody mAbR310 specific for the (R)-HNE-modified protein.Acta crystallographica. Section F, Structural biology and crystallization communications · 2006
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 1 country.

Mitsugu AkagawaGraduate School of Bioagricultural Sciences, Nagoya University, Nagoya 464-8601, Japan.
Sohei Ito
Kazuyo Toyoda
Yoshihisa Ishii
Emi Tatsuda
Takahiro Shibata
Satoru Yamaguchi
Yoshichika Kawai
Kousuke Ishino
Yusuke Kishi
Takahiro Adachi
Takeshi Tsubata
Yoshinari Takasaki
Nobutaka Hattori
Tsukasa Matsuda
Koji Uchida
Nagoya University · JPTokyo Medical and Dental University · JPUniversity of Shizuoka · JPJapan Science and Technology Agency · JPJuntendo University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

4-Hydroxy-2-nonenal (HNE), a racemic mixture of 4R- and 4S-enantiomers, is a major product of lipid peroxidation and is believed to be largely responsible for the cytopathological effects observed during oxidative stress. HNE reacts with histidine to form a stable HNE-histidine Michael addition-type adduct possessing three chiral centers in the cyclic hemiacetal structure. We have previously raised the mAbs, anti-R mAb 310 and anti-S mAb S412, that enantioselectively recognized the R-HNE-histidine and R-HNE-histidine adducts, respectively, and demonstrated the presence of both epitopes in vivo. In the present study, to further investigate the anti-HNE immune response, we analyzed the variable genes and primary structure of these Abs and found that the sequence of R310 was highly homologous to anti-DNA autoantibodies, the hallmark of systemic lupus erythematosus. An x-ray crystallographic analysis of the R310 Fab fragment showed that the R-HNE-histidine adduct binds to a hydrophobic pocket in the antigen-binding site. Despite the structural identity to the anti-DNA autoantibodies, however, R310 showed only a slight crossreactivity with the native double-stranded DNA, whereas the Ab immunoreactivity was dramatically enhanced by the treatment of the DNA with 4-oxo-2-nonenal (ONE), an analog of HNE. Moreover, the 7-(2-oxo-heptyl)-substituted 1,N2-etheno-type ONE-2'-deoxynucleoside adducts were identified as alternative epitopes of R310. Molecular mimicry between the R-HNE-histidine configurational isomers and the ONE-DNA base adducts is proposed for the dual crossreactivity.

Indexed as

AldehydesAmino Acid SequenceAnimalsAntibodies, AntinuclearAntibodies, BispecificAntibodies, MonoclonalAutoantibodiesCross ReactionsCrystallography, X-RayDeoxyribonucleosidesDNADNA AdductsEpitopesImmunoglobulin Fab FragmentsLipid PeroxidationLipids4-hydroxy-2-nonenalAldehydesAntibodies, AntinuclearAntibodies, BispecificAntibodies, MonoclonalAutoantibodiesDeoxyribonucleosidesDNADNA AdductsEpitopesImmunoglobulin Fab FragmentsLipidsProteins

Identifiers

PMID16603628
PMCPMC1458848
OpenAlexW2053510990

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.